IL-1α and IL-1β levels in blood serum and saliva of menopausal women

Endocrine Research

Volumn 38, Issue 2, 2013, Pages 69-76

  Rahnama, Mansur ^a   Jastrzebska, Izabela ^a   Jamrogiewicz, Rafał ^a   Kocki, Janusz ^a  

^a MEDICAL UNIVERSITY OF LUBLIN   (Poland)

Author keywords

Bone density; Cytokines; Marker; Menopause; Osteoporosis

Indexed keywords

INTERLEUKIN 1ALPHA; INTERLEUKIN 1BETA; BIOLOGICAL MARKER; DYDROGESTERONE PLUS ESTRADIOL; ESTROGEN; GESTAGEN;

ADULT; ANAMNESIS; ARTICLE; BLOOD SAMPLING; BONE DENSITOMETRY; BONE DENSITY; CLINICAL ARTICLE; CONCENTRATION (PARAMETERS); FEMALE; HORMONE SUBSTITUTION; HUMAN; OSTEOPOROSIS; POSTMENOPAUSE; PRIORITY JOURNAL; QUESTIONNAIRE; COMPARATIVE STUDY; CONTROLLED STUDY; DENSITOMETRY; MENOPAUSAL SYNDROME; MIDDLE AGED; PROTEIN BLOOD LEVEL; PROTEIN SALIVA LEVEL; SALIVA LEVEL; TREATMENT OUTCOME; TREATMENT RESPONSE; UPREGULATION; BLOOD; DRUG EFFECTS; MENOPAUSE; METABOLISM; PHYSIOLOGY; SALIVA; SECRETION (PROCESS);

BONE DENSITY; FEMALE; HORMONE REPLACEMENT THERAPY; HUMANS; INTERLEUKIN-1ALPHA; INTERLEUKIN-1BETA; MENOPAUSE; MIDDLE AGED; POSTMENOPAUSE; SALIVA;

EID: 84875854829     PISSN: 07435800     EISSN: 15324206     Source Type: Journal    
DOI: 10.3109/07435800.2012.713425     Document Type: Article

References (27)

1. Lerner UH. Bone remodeling in post-menopausal osteoporosis. J Dent Res 2006;85: 584-595. (Pubitemid 44085947)
2. Weitzmann M, Pacifici R. Estrogen deficiency and bone loss: an inflammatory tale. J Clin Invest 2006;116: 1186-1194.
3. Lorentzon M, Lorentzon R, Nordström P. Interleukin-6 gene polymorphism is related to bone mineral density during and after puberty in healthy white males: a cross-sectional and longitudinal study. J Bone Miner Res 2000;15: 1944-1949.
4. Janiec W. Kompendium Farmakologii. Warszawa: PZWL; 2006.
5. Pluskiewicz W, Rogala E. Osteoporoza. Katowice:Śla̧ska Akademia Medyczna; 1995: 9-11.
6. Jȩdrzejczak WW, Podolak-Dawidziak M. Cytokiny. Zastosowanie kliniczne. Wrocław: Wyd. Volumed s. c., 1997.
7. Pacifici R. Estrogen, cytokines, and pathogenesis of postmenopausal osteoporosis. J Bone Miner Res 1996;11: 1043-1051. (Pubitemid 26321353)
8. Kmieć Z, Sokołowska I. Role of tumor necrosis factor family ligands in the pathogenesis of rheumatoid arthritis-new therapeutical opportunities. Pol Merkur Lekarski. 2007;22: 300-304.
9. Dirschnabel AJ, Alvim-Pereira F, Alvim-Pereira CC, et al. Analysis of the association of IL1B(C-511T) polymorphism with dental implant loss and the clusterization phenomenon. Clin Oral Impl Res 2011;22: 1235-1241.
10. Knudsen S, Harslřf T, Husted LB, et al. The effect of interleukin-1a polymorphisms on bone mineral density and the risk of vertebral fractures. Calcif Tissue Int 2007;80: 21-30. (Pubitemid 46095747)
11. Zallone A. Direct and indirect estrogen actions on osteoblasts and osteoclasts. Ann N Y Acad Sci 2006;1068: 173-179. (Pubitemid 43824147)
12. Tani-Ishii N, Tsunoda A, Teranaka T, Umemoto T. Autocrine regulation of osteoclast formation and bone resorption by IL-1 alpha and TNF alpha. J Dent Res 1999;78: 1617-1623. (Pubitemid 32501249)
13. Dinarello CA. Introduction of interleukin-1 and interleukin-1 receptor antagonist. Semin Oncol 1997;24: 81-93.
14. Krum SA, Miranda-Carboni GA, Hauschka PV, et al. Estrogen protects bone by inducing Fas ligand in osteoblasts to regulate osteoclast survival. EMBO J 2008;27: 535-545. (Pubitemid 351225684)
15. Navazesh M, Kumar SK. Measuring salivary flow: challenges and opportunities. J Am Dent Assoc 2008;139: 35-40.
16. Wong DT. Salivary diagnostics powered by nanotechnologies, proteomics and genomics. J Am Dent Assoc 2006;137: 313-321. (Pubitemid 43416224)
17. Mitwally MF, Gotlieb L, Casper RF. Prevention of bone loss and hypoestrogenic symptoms by estrogen and interrupted progestogen add-back in long-term GnRH-agonist down-regulated patients with endometriosis and premenstrual syndrome. Menopause 2002;9: 236-241. (Pubitemid 34743448)
18. Komulainen MH, Kröger H, Tuppurainen MT, et al. HRT and Vit D in prevention of non-vertebral fractures in postmenopausal women: a 5 year randomized trial. Maturitas 2008;61: 85-94.
19. Cohen-Solal M, Graulet A, Gueris J, et al. Bone resorption at the femoral neck is dependent on local factors in nonosteoporotic late postmenopausal women: an in vitro-in vivo study. J Bone Miner Res 1995;10: 307-314.
20. Grobelna M, Mroczko B, Czygier M, Szmitkowski M. Cytokiny jako markery osteolizy w diagnostyce pacjentów z przerzutami nowotworowymi do kości. Postepy Hig Med Dosw 2008;62: 668-675.
21. Di Iorio A, Ferrucci L, Sparvieri E, et al. Serum IL-1β levels in health and disease: a population-based study. 'The InCHIANTI study'. Cytokine 2003;22: 198-205. (Pubitemid 36900387)
22. Mirrielees J, Crofford LJ, Lin Y, et al. Rheumatoid arthritis and salivary biomarkers of periodontal disease. J Clin Periodontol 2010;37: 1068-1074.
23. Wilson R, Spiers A, Ewan J, et al. Effects of high dose oestrogen therapy on circulating inflammatory markers. Maturitas 2009;62: 281-286.
24. Cantatore FP, Loverro G, Ingrosso AM, et al. Effect of oestrogen replacement on bone metabolism and cytokines in surgical menopause. Clin Rheumatol 1995;14: 157-160.
25. Vural P, Akgul C, Canbaz M. Effects of hormone replacement therapy on plasma pro-inflammatory and anti-inflammatory cytokines and some bone turnover markers in postmenopausal women. Pharmacol Res 2006;54: 298-302. (Pubitemid 44233334)
26. Cyprysiak G, Tadeusiak W. Zastosowanie śliny w diagnostyce medycznej. Nowa Stomatol 2001;2: 33-36.
27. Król K, Grocholewicz K. Some salivary proteins as a biomarkers of local and general diseases. Literature review. Ann Acad Med Stetin. 2007;53: 78-82.